Latest filing published 29 Sept 2026 for Kura Oncology, Inc., €115k.
Filing timeline
BuySaleInsider track record
Mollie Leoni: trading record in brief
Mollie Leoni discloses dealings in Kura Oncology, Inc. to SEC (Form 4). We count 16 filings; the first trade dates from 2 January 2025 and the latest from 29 September 2026.
On the market, this insider has only sold: 12 sales, €725k in total. Outside the open market, there are 4 share grants. 2026 to date brings no purchases and 6 sales.
The latest filing, published on 29 September 2026, reports an open-market sale of €115k in Kura Oncology, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mollie Leoni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,448 shares@ US$10.49730.014% mcap26.7% of flowCommon StockSEC:0001193125-26-407937:0
- 28,802 shares@ US$10.74810.032% mcap63.3% of flowCommon StockSEC:0001193125-26-407937:1
- 3,655 shares@ US$8.460760.5% of flowCommon StockSEC:0001193125-26-025303:0
- 50,000 shares0Common StockSEC:0001193125-26-004570:0
- 82,500 shares0Common StockSEC:0001193125-25-283563:0
- 82,500 shares0Common StockSEC:0001193125-25-223664:0
- 2,253 shares@ US$7.871939.5% of flowCommon StockSEC:0000950170-25-010121:0
- 46,250 shares0Common StockSEC:0001415889-25-001052:0
8 of 8 declarations
